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Abstract
Constraint-based models of metabolic networks are typically underdetermined, because they contain more reactions than
metabolites. Therefore the solutions to this system do not consist of unique flux rates for each reaction, but rather a space
of possible flux rates. By uniformly sampling this space, an estimated probability distribution for each reaction’s flux in the
network can be obtained. However, sampling a high dimensional network is time-consuming. Furthermore, the constraints
imposed on the network give rise to an irregularly shaped solution space. Therefore more tailored, efficient sampling
methods are needed. We propose an efficient sampling algorithm (called optGpSampler), which implements the Artificial
Centering Hit-and-Run algorithm in a different manner than the sampling algorithm implemented in the COBRA Toolbox for
metabolic network analysis, here called gpSampler. Results of extensive experiments on different genome-scale metabolic
networks show that optGpSampler is up to 40 times faster than gpSampler. Application of existing convergence diagnostics
on small network reconstructions indicate that optGpSampler converges roughly ten times faster than gpSampler towards
similar sampling distributions. For networks of higher dimension (i.e. containing more than 500 reactions), we observed
significantly better convergence of optGpSampler and a large deviation between the samples generated by the two
algorithms. Availability: optGpSampler for Matlab and Python is available for non-commercial use at: http://cs.ru.nl/
,wmegchel/optGpSampler/.
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Introduction
Modelling metabolic networks helps to unravel the complex
machinery of metabolism within the cell. A classic approach is to
model the reaction pathways in a dynamic fashion, using detailed
kinetic data. For genome-scale models, often involving hundreds
or thousands of reactions and metabolites, it is experimentally
prohibitive to obtain the kinetic parameters involved. A constraint-
based approach has successfully been applied to model and
address a wide range of biological questions in the absence of
detailed kinetic data [1,2]. By using a steady-state assumption, a
first type of constraint dictates that all metabolite concentrations
stay constant over time (mass-balance). A second type of constraint
limits the flux rate for each reaction (flux-capacity and direction-
ality). The relation between the m metabolites and n reactions is
described in the m|n stoichiometric matrix S. A positive
stoichiometric coefficient Si,j means that the metabolite i is
produced by reaction j and a negative entry indicates that the
metabolite is consumed in that reaction. At steady-state, the mass-
balance and flux capacity constraints can be formulated as in eq.
(1) and inequality (2) respectively.
d~x
dt
~S~v~0, ð1Þ
vj,minƒvjƒvj,max,Vj[f1 . . . ng, ð2Þ
where~x and~v are vectors of metabolite concentrations and flux
rates respectively. Each flux rate vj is bounded by inequality
constraint (2). Although in some cases the bounds are known from
experiments, for most reactions this is not the case and arbitrarily
large values are used. Since the matrix S is a system of linear
equations, the constraints in eq:mass-balance and inequality (2)
form a bounded convex space [3], containing all possible values of
~v. A major challenge is to characterize the biologically interesting
flux distributions among all alternatives. Since the stoichiometric
matrix is fixed, the remaining possibility is to add additional
constraints or tighten the inequality bounds in (2). This can be
done by incorporating measured flux data, which is often
laborious, expensive or difficult to obtain, even for a small subset
of all reactions.
PLOS ONE | www.plosone.org 1 February 2014 | Volume 9 | Issue 2 | e86587
Many constraint-based methods have been proposed to find flux
distributions that are of biological interest. A successful approach is
Flux Balance Analysis (FBA) [4], that introduces a biologically
relevant objective function and uses linear programming to find a
flux distribution that optimizes this objective. FBA proved to be
especially useful for cell types with a well-defined objective
function, such as maximum growth for unicellular species.
Although FBA has successfully been applied to determine possible
phenotypes and byproduct secretion in various experimental
settings, it is often unable to determine the underlying (internal)
flux states [5]. Furthermore, for many objective functions, a wide
range of alternative optima exists [6].
In order to obtain an estimated probability distribution of
attainable flux values for each reaction in the network, methods
based on uniform sampling are used. A fast algorithm for this task
is called hit-and-run (HR) [7]. HR collects samples by iteratively
choosing a random direction and a random step size in that
direction such that the next point also resides in the solution space.
For the irregularly shaped solution spaces of metabolic networks
the Artificial Centering Hit-and-Run (ACHR) algorithm [8] is
better suited, because it is tailored to sample in the elongated
directions of the solution space. Partly based on ACHR, the
uniform random sampling procedure known as gpSampler is often
used to sample metabolic networks and implemented in the
COnstrained Based Reconstruction and Analysis (COBRA)
Toolbox [9]. Although these algorithms are often referred to as
uniform random samplers, their convergence behaviour in the
context of genome-scale metabolic networks has not yet been
thoroughly investigated. Besides its irregular shape, the solution
space of genome-scale metabolic networks are often high-
dimensional, containing hundreds to almost a thousand dimen-
sions as in the human metabolic network reconstruction.
Therefore in this paper we investigate uniform random
sampling in the context of metabolic networks. Our contributions
are threefold: (1) we introduce an efficient and effective random
sampling algorithm which combines the advantages of ACHR and
gpSampler; (2) we propose a new measure to quantify the deviation
between samples obtained from two independent sampling runs;
(3) we perform a thorough analysis on five metabolic network
models.
Methods
Uniform Random Sampling
One of the first attempts to sample the flux states in a metabolic
network used a rejection sampling technique [10]. In rejection
sampling, the space of interest is enclosed by a regular shape, such
as a parallelepiped. Samples are drawn from the uniform
distribution over the parallelepiped and rejected if they violate
the constraints for the enclosed space of interest. The nice feature
of rejection sampling is that the samples are uniformly distributed
over the enclosed space. However, fitting a regular shape tightly
around the space of interest is hard and often impossible. This
means that in higher dimensions, the volume of the enclosing
shape grows explosively compared to the volume of the shape of
interest [7]. In this case, a very large fraction of the samples have
to be rejected, making rejection sampling an inefficient method for
genome-scale models.
The hit-and-run (HR) algorithm [7] mitigates this problem,
because it samples directly from the solution space (see Fig. 1). Hit-
and-run starts from a point~x0 in the bounded space. It chooses an
arbitrary direction ~u1 from the uniform distribution on the
boundary LB of the unit sphere in Rn. The distance from~x0 to the
boundary of the solution space in the direction of ~u1 determines
the maximum distance it can travel. An arbitrary step size l1 is
selected in the (negative) direction of~u1, such that the sampler does
not step out of the constrained space. The next point ~x2 is
determined by travelling distance l1 in the direction ~u1. By
iterating this process, HR generates a chain of consecutive sample
points. The fact that HR uses only the current point to obtain the
next sample makes it a Markov Chain Monte Carlo (MCMC)
method [11], which has been shown to converge towards the
target distribution (uniform in our setting).
In general, the constraints in metabolic network models lead to
a convex space of irregular shape which is elongated for reactions
whose flux rates are loosely constrained, and is narrow for tightly
constrained fluxes. A consequence of this phenomenon is that
many sample points are close to the boundary of the solution
space. Since HR chooses a direction~ui uniformly from all possible
directions, this enforces the sampler to perform small steps, so the
next generated point is close to the previous one. In practice this
prevents the sampler to fully explore the rest of the solution space.
ACHR [8] alleviates the problem of getting trapped in regions
close to the boundary because it tries to sample in the elongated
directions, thus making larger steps possible. It iteratively
generates samples by using an ‘artificial’ centre of the space,
which is empirically estimated at each iteration using the points
sampled so far. ACHR consists of two phases: warm-up and (main)
sampling. In the warm-up phase an arbitrary initial point ~x0 in the
solution space is selected to generate a chain ~x0, . . . ,~xW of W§n
points. The requirement W§n ensures that after the warm-up
phase, the set of directions spans LB with probability one [8].
Then the main sampling phase starts from ~xW . By iteratively
updating the empirical centre and by using a direction from a
randomly chosen previous sampled point to this centre, ACHR
Figure 1. Illustration of hit-and-run. Hit-and-run starts at the point
x0 in the solution space S. It chooses a random direction u1 and
determines the maximum distance it can travel forwards or backwards
in that direction. A random step size l1 is chosen on the line u1[S. The
next point x1 is obtained by travelling l1 in the direction u1 . By iterating
this process T times, samples are obtained that are uniformly
distributed in the space, when T??.
doi:10.1371/journal.pone.0086587.g001
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explores elongated directions of the space. Figure 2a illustrates the
warm-up and the main sampling phase of ACHR.
The sequence of ACHR iterates is not a Markov chain, due to
the dependence of directions on prior iterates. Thus the sequence
of iterates is not guaranteed to converge to a uniform distribution
[8].
ACHR is at the core of gpSampler [9], a popular sampling
algorithm for metabolic network analysis. Figure 2b illustrates how
gpSampler works. The highly irregular shape of the solution space of
metabolic networks makes a uniform direction choice on LB a
poor choice. Therefore, in order to generate a number of T
samples, gpSampler’s warm-up phase uses linear programming in a
two parts procedure. In part (1) 2n warm-up points are generated
by consecutively minimizing and maximizing the flux rate of each
reaction. In part (2) the remaining T{2n warm-up points are
generated by assigning random weights to the fluxes that should be
optimized. The optimal solutions (and thus the warm-up points)
for a linear program reside on the boundary of the constrained
space [12]. Often, this causes the allowed step sizes to become very
small, which makes it hard to move away from the boundary.
Therefore, gpSampler uses a linear transformation to ‘pull’ the
warm-up points more into the interior of the solution space. Then,
each moved warm-up point is used in the main sampling phase to
generate T separate chains of length k. The user provided step count
parameter k determines the number of ACHR iterates between
the starting point ~xW and the end point ~xWzk of each chain.
Finally, the T end points of the chains are returned as samples.
optGpSampler
We propose to combine a part of the warm-up phase of
gpSampler and ACHR. The resulting algorithm is called optGpSam-
pler (see Table 1. Algorithm 1). First, 2n warm-up points are
Figure 2. Conceptual difference between the samplers. Conceptual difference between (a) ACHR, (b) gpSampler and (c) optGpSampler. Warm-
up points are depicted as gray rectangles, samples that are stored as gray circles. Uncoloured circles denote points that are visited by the sampler,
but are not stored as a sample. a) The original ACHR algorithm starts at a point~x0 and iteratively moves to a next point~xi =~xi{1zli~ui . One chain is
used, with step count k = 1. The chain contains W warm-up points and T samples. b) GpSampler uses the linear programming procedure described
in the main text to find T warm-up points. Then, each of the warm-up points is iteratively moved in the space in the same fashion as the ACHR
algorithm in (a), leading to T sampling chains. Each chain of length k returns its end point as a sample. c) OptGpSampler obtains 2n warm-up points.
For each of the p processors used, a warm-up point is chosen randomly as the initial point~x0
j , with j[f1,2, . . . ,pg. Starting from the warm-up points,
new points are found in the same fashion as for the ACHR algorithm in (a), but now only every kth point is kept as a sample. Again, the result is T
sample points, but now these have travelled k up to kT=p steps from a warm-up point. Compared to gpSampler, it uses less but much longer
sampling chains.
doi:10.1371/journal.pone.0086587.g002
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generated using part (1) of gpSampler’s warm-up procedure by
successively minimizing and maximizing the flux through each
reaction. We do not generate T warm-up points as in gpSampler
because running a linear program on a large network is much
more time-consuming than random sampling. Moreover, although
the weight vector for the linear program is randomly chosen, the
constraints in eq. (1) and inequality (2) often lead to the same or a
similar optimal solution. This could bias the starting points and
directions choice of our sampler.
The sampling phase of optGpSampler is similar to that of ACHR
(see Fig. 2c), but only selects a sample at each k iterates.
Furthermore, instead of generating one chain of consecutive
sample points, optGpSampler exploits p processors and generates p
chains in parallel. In practice, the desired number of sample points
T is much larger than the number of available processors p. This
makes the length of the chains generated by optGpSampler a factor
of T=p longer than those generated by gpSampler.
We implemented optGpSampler in C++ and used Armadillo [13],
a fast linear algebra library. OpenMp [14] was utilized to start a
separate chain on p processor cores in parallel. Interfaces for
Matlab and Python enable users to easily sample existing models
with optGpSampler or integrate our sampler in new methods.
Experiments
Datasets
We benchmarked gpSampler and optGpSampler on five publicly
available reconstructions of genome-scale metabolic networks
[14]. All reactions and associated metabolites that could not carry
a flux were removed from the models prior to the sampling. The
network size remaining after this preprocessing step, i.e. the
number of m metabolites and n reactions is given between
brackets. In ascending size order, we used E. coli central
metabolism (68, 87), C. thermocellum iSR432 (288, 351), S.
cerevesiae iND750 (479, 631), E. coli iAF1260 (1032, 1532) and
H. sapiens recon 1 (1587, 2469).
Evaluation
We assessed efficiency and quality performance of gpSampler and
optGpSampler. Efficiency was measured using runtime. Quality
performance in our context amounts to measure the capability
of a sampler to effectively generate points uniformly distributed
in the solution space. Since both gpSampler and optGpSampler have
no theoretical convergence guarantees, we use two methods:
empirical convergence diagnostics and a new method called
xy-deviation.
Empirical Convergence Diagnostics
Empirical convergence diagnostics are used to test whether the
sampled distribution converges towards a stationary one. There is
not always good agreement between different convergence
diagnostic methods [16]. Therefore we use the following three
convergence diagnostics tests: Gelman and Rubin [17], Geweke
[18] and Heidelberger and Welch (HW) [19]. They are available
in the Convergence Diagnosis and Output Analysis (CODA)
Toolbox for MCMC [20].
The Gelman and Rubin test is multivariate: it returns a so called
R value (with R§1:0). R values smaller than 1.2 indicate
convergence, with values closer to 1.0 indicating better results.
The other two tests are univariate. The Geweke test returns a z-
value for each reaction, with lower values indicating better
convergence. The HW test returns whether a sample distribution
for a given reaction converged (value = 1) or not (value = 0).
Table 1. Algorithm 1.
Input: S: the solution space; T : sample count; k: step count, p: number of processors;
output: P: sequence of T sampled points;
/* Warm-up phase */
1 Generate 2n warm-up points as in part (1) of gpSampler’s warm-up phase;
/* Sampling-phase */
2 P~vw;
3 L~qTk=pr ;
4 for i = 1 to p do
5 ~x0~ a point randomly chosen from the 2n warm-up points;
6 for j =1 to L do
7 ~xj =point generated from ~xj{1 by performing one iterate of the ACHR sampling phase;
8 if j mod k = = 0 then
9 P~vP,~xjw;
10 end
11 end
12 end
optGpSampler(S, T , k, p).
doi:10.1371/journal.pone.0086587.t001
Table 2. Runtimes for the networks analysed.
Network
name m n N(S)
Time
Gp (SD)
Time
optGp (SD)
E. coli
core
68 87 24 137.16
(0.62)
3.63
(0.05)
C. therm.
iSR432
288 351 70 258.57
(0.54)
10.20
(0.05)
S. cerev.
iND750
479 631 180 496.57
(3.07)
21.81
(0.04)
E. coli
iAF1260
1032 1532 525 1474.01
(6.78)
95.78
(2.62)
H. sapiens
recon 1
1587 2469 932 2910.26
(43.57)
349.05
(0.48)
The number of metabolites and reactions is denoted by m and n respectively.
The dimensionality of the nullspace of S, is given by N(S). Time gp (SD) is the
mean runtime (seconds) and standard deviation for sampling T = 50.000 points
using gpSampler. Time optGp (SD) denotes the same figures for optGpSampler.
Experiments were performed on a 16 GB RAM AMD Phenom desktop pc.
doi:10.1371/journal.pone.0086587.t002
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xy-Deviation
In general, a larger step count gives a sample distribution that is
closer to the target distribution, at the expense of a longer runtime.
Therefore, we introduce a measure called xy-deviation that
quantifies how samples generated by sampler x using a given step
count k1 deviate from those generated by sampler y using a much
larger step count k2. Specifically, a small deviation indicates that the
sample distribution generated by sampler x converged empirically
to the target distribution of y.
Given samplers x and y, step counts k1 and k2, with k2 very
large (k2~5000 in our experiments), the number c of runs, and
the number T of samples, xy-deviation is computed as follows.
1. Perform c runs of sampler x with step count k1, and c runs of
sampler y with step count k2, where each run generates T
samples.
2. Sort the points in each run (e.g., in increasing order), producing
c sorted chains of points for sampler x and y: vxjb,iw,
vyjb,iw, b[f1, . . . ,Tg, j[f1, . . . ,ng, i[f1, . . . ,cg.
3. For each reaction j, normalize the flux rates: we divide x
j
b,i
(resp. y
j
b,i) by the difference between the upper and lower
bounds of vj :
X
j
b,i~
x
j
b,i
vj,max{vj,min
, Y
j
b,i~
y
j
b,i
vj,max{vj,min
,
i[f1, . . . ,cg, j[f1, . . . ,ng, b[f1, . . . ,Tg.
4. Compute the mean chain of the c runs of y:
Y
j
b~
1
c
Xc
i~1
Y
j
b,i, j[f1, . . . ,ng, b[f1, . . . ,Tg.
5. Our assumption is that chains generated by sampler x
that converge will have small deviation from the ‘average-chain’
generated by y. For each reaction j, we measure such deviation
by computing the mean absolute deviation over the chains
generated by x from Yjb: D
j~
1
c|T
Xc
i~1
XT
b~1
DXjb,i{ Y
j
bD,
j[f1 . . . ng.
Our choice to use a mean deviation over the standard deviation
is motivated by the fact that the mean deviation is more efficient
than the standard deviation in the realistic situation where some of
the measurements are in error, and more efficient for distributions
other than perfect normal [21]. Note that the range of Dj is [0,1],
and can be expressed as a percentage, which makes it convenient
to compare deviations across different reactions.
Figure 3. Empirical convergence for C. thermocellum iSR432. (a) Convergence according to the Geweke diagnostic. (b) Convergence
according to the Heidelberger-Welch diagnostic. Convergence for optGpSampler is observed at approximately 500 steps. For gpSampler, both
diagnostics only agree on convergence after k = 5000 steps. Notice the higher HW convergence fraction of the latter at k =50 steps and at k = 5000
steps compared to the steps in between.
doi:10.1371/journal.pone.0086587.g003
Figure 4. xy-deviation for C. thermocellum iSR432. xy-deviation from samples obtained with sampler x at step count k1 to sampler y using
k2 = 5000. (a) Deviation to samples obtained by y= gpSampler. (b) Deviation from samples obtained by y= optGpSampler. In both cases optGpSampler
converges much faster to sampler y.
doi:10.1371/journal.pone.0086587.g004
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6. Then the xy-deviation over c chains with respect to k1 and k2 is
defined as the average of the reaction deviations:
D~
1
n
Xn
j~1
Dj ð3Þ
Small values of xy-deviation indicate convergence of x to y. In the
experiments we analysed self-deviation (xx-deviation) and cross-
deviation (xy-deviation, with x and y different samplers) for
different values of k1.
Results
We used the gpSampler implementation in the COBRA Toolbox.
Results of extensive experiments are given in supplementary
material. Tables S1–S5 in File S1 provide results for all the
runtime experiments performed. Figures S1–S6 in File S1 provide
the results of the convergence diagnostic tests and xy-deviation.
We visualized how a small or large xy-deviation translates to a
similar or (highly) dissimilar sample distribution in figures S7–S11
in File S1.
Efficiency
We sampled all networks four times using T =10, 50 and 100
thousand samples, with step count k=50. Both gpSampler and
optGpSampler were executed in parallel mode on an AMD desktop
computer using p=4 processor cores in parallel. Efficiency results,
summarized in Table 2, show that optGpSampler is roughly 6 to 40
times faster than gpSampler.
Quality
To asses the quality of the results, we performed four
independent runs with each sampler. Each run collected
T =50.000 samples and was repeated for six different step counts
(k[f50,250,500,1000,2500,5000g).
We ran all convergence diagnostics with the default settings in
the CODA package. The convergence tests results were averaged
over the four runs. A univariate test for a sampler outputs a vector
of length n. Significance of the difference between gpSampler and
optGpSampler was assessed by applying the Wilcoxon signed-rank
test to the corresponding vectors. The results for the Gelman and
Rubin test indicated convergence for all experiments, in disagree-
ment with results of the Geweke and HW tests.
The obtained chains were also used to compute the xy-
deviation for the above given step count k1, and k2 =5000. All
Figure 5. Empirical convergence for E. coli iAF1260. (a) Convergence according to the Geweke diagnostic. (b) Convergence according to the
Heidelberger-Welch diagnostic. For both convergence tests, gpSampler’s performance deteriorates when the step count is increased up to k =2500.
Especially the good scores at low values of k seem unrealistic and could indicate convergence towards a non-uniform distribution. Results for
optGpSampler seem more stable and more reliable.
doi:10.1371/journal.pone.0086587.g005
Figure 6. xy-deviation for E. coli iAF1260 xy-deviation from samples obtained with sampler x at step count k1 to sampler y using
k2 =5000. (a) Deviation to samples obtained by y= gpSampler. (b) Deviation from samples obtained by y= optGpSampler. Self-deviation (x~y) is
small for both samplers, but there is a large cross-deviation (x=y). For this large network, the we do not observe convergence of gpSampler to the
samples obtained by optGpSampler or vice versa as in Fig. 4.
doi:10.1371/journal.pone.0086587.g006
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sample chains were compared by the average of the four chains
obtained at the highest step count of k=5000.
Small networks (less than 500 reactions). On the E. coli
central metabolism network, the Geweke test returned relatively low
z-values for both gpSampler and optGpSampler (see figure S1 in File
S1). Results of the HW test indicated that optGpSampler converged
rapidly, at k=50 step count. Both the Geweke and HW tests
showed that gpSampler needs a step count close to 500 to converge.
Results of xy-self-deviation demonstrate a large deviation of
samples generated by gpSampler with a small step count from those
generated with a higher step count. In general, results showed that
optGpSampler with a low step count generates samples that are both
close to those generated using a higher step count with the same
sampler and to those generated by gpSampler with a higher step
count.
On the C. thermocellum iSR432 network, the HW test showed
significantly higher convergence rates for optGpSampler (see Fig. 3).
Both the Geweke and HW tests showed that optGpSampler
converged at step counts bigger than 1000. The situation for
gpSampler is different: the values of the HW test dropped at step
count 250 and then increased significantly when the step count
reached 5000. This indicates two distinct points of convergence,
one at small step count values and one at large values. This
behaviour can be explained by the way gpSampler collects its
samples. It starts at a warm-up point and uses k iterates of the
ACHR algorithm to obtain a sample point. It repeats this process,
each time starting from a different warm-up point (see Fig. 2b).
These warm-up points turn out to be close to each other, as a
consequence of the linear programming procedure used. Thus
gpSampler often starts the sampling from the same area of the
solutions space. In higher dimensions, a small step count can
prevent gpSampler to ‘travel’ far from the warm-up points. In this
case the small step count causes gpSampler to show a bias towards
the regions close to the warm-up points and the sampling chain
converges towards these regions. The large xy-deviation (see
Figure 4) shows that the samples collected are different from those
sampled at a higher step count.
The results for gpSampler at large step count (k=5000 steps)
again indicates convergence. In this case the small xy-deviation
indicates that an extended region is covered by the samples. Since
optGpSampler does not restart at a warm-up point, it is better able to
‘escape’ from the regions near the warm-up points because it
effectively uses much longer chains. Therefore, its convergence
and xy-deviation results are better.
Large networks (at least 500 reactions). The convergence
and results for the S. cerevisiae iND750 (see figure S3 in File S1) and
especially the E. coli iAF1260 network in Fig. 5 showed an even
more surprising result. For these larger models, the convergence
results for gpSampler declines when the step count is increased. For
optGpSampler, we still observed an increasing convergence perfor-
mance for the yeast network, although a much larger step count
(k~2500) was required. The more stable results for the larger E. coli
iAF1260 network could be an effect of the minimum glucose
setting of this network, which significantly reduces the attainable
flux states. The xy-deviation results in Fig. 6 indicate that the
samplers give completely different sampling results. The self-
deviation shown in Fig. 6, reveals a small variability within the four
independent runs for each sampler. This means that both samplers
give relatively stable results, and thus that the deviation results
observed between the samplers must be due to the difference
between the algorithms.
Finally, the results for the human network reconstruction (see
figures S5 and S6 in File S1) indicate that gpSampler converges
already at low k. Although we believe that the sample distributions
indeed converged in this case, it seems unlikely that they represent
a uniformly distributed sample. First, the high dimensionality of
almost a thousand and the declining results for the Geweke test
make this unlikely. Next, the huge deviation with samples obtained
by optGpSampler indicate a non-uniform distribution, especially
since we saw that optGpSampler performs better on the smaller
networks. The convergence results for optGpSampler seem more
realistic, with a relatively large z-value and a HW test result that
indicates that around 60% of the sampled flux distributions
converged.
Discussion
We proposed a new algorithm for uniform sampling of the
steady-state solution space of metabolic networks. Our algorithm
also implements ACHR, but in a different manner than the state-
of-the-art sampling method for metabolic networks (gpSampler). We
compared the runtimes with those of gpSampler, and showed its
superior efficiency. We investigated empirical convergence using
different diagnostics and showed faster convergence of optGpSam-
pler on the two smaller networks studied. Moreover, by using the
here introduced xy-deviation measure, we compared the sampled
distributions. For smaller networks, the samples obtained by
optGpSampler using a small step count are close to those obtained
with a high step count by both optGpSampler and gpSampler.
On three large networks the convergence performance of
gpSampler diminishes when the step count increases. We hypoth-
esized that the approach gpSampler takes by starting each sample
chain at a warm-up point, together with the high dimensionality of
the solution space, restrains its ability to move from the vicinity of
these warm-up points. Because our method continues the ACHR
procedure from the last collected point, it effectively uses much
larger step counts. Therefore, optGpSampler is more likely to escape
the regions near the warm-up points, leading to a better sampling
result.
For the larger networks, results showed that the convergence
observed at lower step counts does not reflect a convergence
towards the target distribution, since the sample distributions
deviate significantly from those generated using a large step count.
Therefore, especially larger networks should be sampled with a
high step count.
To the best of our knowledge there is no method to assess
whether samples are truly uniformly random distributed in a convex
space of unknown shape. Since the chains generated by ACHR are
not Markov chains, asymptotic convergence guarantees also do not
hold for both gpSampler and optGpSampler. Therefore convergence
results should be interpreted with caution. The accelerated
convergence of ACHR towards a uniform distribution was
demonstrated by [8] for convex polytopes of known shape. However
it remains uncertain to what extent the samples obtained by ACHR
for the irregular solution space of metabolic networks are truly
uniformly distributed. As expected, our experiments indicate that
convergence results deteriorate when the dimensionality of the
solution space increases, and that for the large genome-scale
metabolic networks, using a large step count is advisable.
We envisage the provided implementation of optGpSampler will
be beneficial to constraint-based metabolic network analysis, as it
provides an efficient and versatile algorithm for sampling the
irregular solution space of metabolic networks.
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